中文 English

Kun Zhang Elected as Fellow of the American Institute for Medical and Biological Engineering (AIMBE)

March 20th, 2017 – Washington, D.C.

Kun Zhang was elected as Fellow of the American Institute for Medical and Biological Engineering (AIMBE) at its annual meeting held at the National Academy of Sciences. As an organization affiliated with the National Academy of Sciences, AIMBE is committed to supporting innovations in medical and biological engineering to benefit society. Becoming a member of the AIMBE College of Fellows is the highest academic honor for the field of medical and biological engineering in the United States. the College of Fellows is comprised of the most outstanding biomedical engineers who are nominated by their peers. Kun Zhang was awarded his AIMBE fellowship for his contributions to genomics and epigenetics.

Kun Zhang is Professor in the Department of Bioengineering at the University of California San Diego. He is a co-founder and a scientific consultant for Singlera Genomics, Inc. Dr. Zhang graduated with a Ph.D. in Human and Molecular Genetics from the University of Texas at Houston, MD Anderson Cancer Center and completed his post-doctoral training with George Church at Harvard Medical School. Dr. Zhang completed the first single cell whole genome sequence (2006 Nature Biotechnology). Along with Dr. Yuan Gao, co-founder of Singlera Genomics, Dr. Zhang developed the first large-scale DNA methylation sequencing technology (2009 Nature Biotechnology). In a 2011 Nature publication, his report on the genomic instability of induced stem cells (iPSC) was listed among the top 10 citations from Nature. Dr. Zhang led the brain genome sequencing project published in the journal Science in 2016. His March 2017 Nature Genetics article which discussed methods for early cancer detection and identifying cancer tissue-of-origin was honored as an innovative technology that is expected to advance the development of tumor liquid biopsy technologies.
返 回